These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1502 related articles for article (PubMed ID: 8744727)

  • 1. Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma.
    Zeuthen J; Birck A; Straten PT
    Arch Immunol Ther Exp (Warsz); 1995; 43(2):123-33. PubMed ID: 8744727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma.
    thor Straten P; Becker JC; Seremet T; Bröcker EB; Zeuthen J
    J Clin Invest; 1996 Jul; 98(2):279-84. PubMed ID: 8755635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of T cell receptor alpha beta variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions.
    Schøller J; thor Straten P; Birck A; Siim E; Dahlström K; Drzewiecki KT; Zeuthen J
    Cancer Immunol Immunother; 1994 Oct; 39(4):239-48. PubMed ID: 7954526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell receptor V beta gene expression differs in tumor-infiltrating lymphocytes within primary and metastatic melanoma.
    Nitta T; Bell R; Okumura K; Sato K; Steinman L
    Cancer Res; 1991 Oct; 51(20):5565-9. PubMed ID: 1655255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.
    Weidmann E; Whiteside TL; Giorda R; Herberman RB; Trucco M
    Cancer Res; 1992 Nov; 52(21):5913-20. PubMed ID: 1382847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.
    Thor Straten P; Schøller J; Hou-Jensen K; Zeuthen J
    Int J Cancer; 1994 Jan; 56(1):78-86. PubMed ID: 8262682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope.
    Cole DJ; Weil DP; Shamamian P; Rivoltini L; Kawakami Y; Topalian S; Jennings C; Eliyahu S; Rosenberg SA; Nishimura MI
    Cancer Res; 1994 Oct; 54(20):5265-8. PubMed ID: 7522957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas.
    Ikeda H; Sato N; Matsuura A; Kikuchi K
    Cancer Res; 1993 Jul; 53(13):3078-84. PubMed ID: 8391386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited T cell antigen receptor repertoire in tumor-infiltrating lymphocyte and inhibition of experimental lung metastasis of murine melanoma by anti-TCR antibody.
    Wang R; Taniguchi M
    J Immunol; 1995 Feb; 154(4):1797-803. PubMed ID: 7836764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytolytic T-cell clones define HLA-A2-restricted human cutaneous melanoma peptide epitopes: correlation with T-cell receptor usage.
    Maeurer MJ; Hurd S; Martin DM; Storkus WJ; Lotze MT
    Cancer J Sci Am; 1995; 1(2):162-70. PubMed ID: 9166469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of T-cell receptor alpha/beta variability in lymphocytes infiltrating a melanoma metastasis.
    Ferradini L; Roman-Roman S; Azocar J; Avril MF; Viel S; Triebel F; Hercend T
    Cancer Res; 1992 Sep; 52(17):4649-54. PubMed ID: 1324789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [T-cell receptor repertoire in tumor infiltrating lymphocytes within malignant brain tumors].
    Nitta T; Ikeda M; Cogen P; Steinman L; Sato K
    No Shinkei Geka; 1992 May; 20(5):559-66. PubMed ID: 1317945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion.
    Ferradini L; Mackensen A; Genevée C; Bosq J; Duvillard P; Avril MF; Hercend T
    J Clin Invest; 1993 Mar; 91(3):1183-90. PubMed ID: 8450047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell receptor repertoire of lymphocytes infiltrating cutaneous melanoma is predominated by V alpha specificities present in T-cells of normal human skin.
    Strohal R; Paucz L; Pehamberger H; Stingl G
    Cancer Res; 1994 Sep; 54(17):4734-9. PubMed ID: 8062272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shared amino acid sequences in the ND beta N and N alpha regions of the T cell receptors of tumor-infiltrating lymphocytes within malignant glioma.
    Ebato M; Nitta T; Yagita H; Sato K; Okumura K
    Eur J Immunol; 1994 Dec; 24(12):2987-92. PubMed ID: 7805726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
    J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the T-cell receptor beta-chain variable region TCRBV14 in HLA-A2-matched primary human melanomas.
    Salvi S; Segalla F; Rao S; Arienti F; Sartori M; Bratina G; Caronni E; Anichini A; Clemente C; Parmiani G
    Cancer Res; 1995 Aug; 55(15):3374-9. PubMed ID: 7614474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer.
    Peoples GE; Davey MP; Goedegebuure PS; Schoof DD; Eberlein TJ
    J Immunol; 1993 Nov; 151(10):5472-80. PubMed ID: 8228239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for T-cell clonal expansion in a patient with squamous cell carcinoma of the head and neck.
    Caignard A; Dietrich PY; Morand V; Lim A; Pannetier C; Leridant AM; Hercend T; Even J; Kourilsky P; Triebel F
    Cancer Res; 1994 Mar; 54(5):1292-7. PubMed ID: 8118818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
    Weidmann E; Logan TF; Yasumura S; Kirkwood JM; Trucco M; Whiteside TL
    Cancer Res; 1993 Oct; 53(20):4745-9. PubMed ID: 8402652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.